Quality of Life Assessment: Key Issues in the 1990sS.R. Walker, Rachel M. Rosser Springer Science & Business Media, 2012 M12 6 - 487 pages It was over five years ago that the Centre for Medicines Research organized a workshop entitled "Quality of Life: Assessment and Application". This workshop brought together a unique group of participants, some of whom had been involved in studies on quality of life for well over a decade, whilst others were meeting the subject for the first time. This blend of experienced researchers and enthusiastic newcomers was a great stimulus to the discus sions which followed individual presentations as well as that resulting from the study groups. In the ensuing publication, a balance was sought between a consideration of the complex principles underlying the assessment of quality of life and the application of such assessments to specific clinical conditions which necessitated this approach. The organization in 1991 of a second workshop entitled "Quality of Life Assessment: Key Issues in the 1990s" resulted in a further consideration of the quality of life philosophy, concepts and key instruments together with an update on assessing quality of life in a number of major disease areas. Of particular importance was an examination of various viewpoints concerned with ethical questions and their implications, and quality oflife from industry, regulatory and health care purchasers' perspectives. As a result of this second workshop, the editors of the original book referred to above decided to produce a second edition with a number of updates and additional chapters. |
From inside the book
Results 6-10 of 89
Page 6
... important functions of some of the new quality of life measures described here ( see the chapter by Kaplan and Anderson , and the chapter by Williams , for more details ) . DISTINGUISHING THE FOREST FROM SOME METHODOLOGICAL TREES How do ...
... important functions of some of the new quality of life measures described here ( see the chapter by Kaplan and Anderson , and the chapter by Williams , for more details ) . DISTINGUISHING THE FOREST FROM SOME METHODOLOGICAL TREES How do ...
Page 7
... important impetus for developing quality of life measurements is for use in clinical trials , where data must be ... importance of the answers sought and the likelihood that the study will provide them , not by THE NEW ERA OF QUALITY OF ...
... important impetus for developing quality of life measurements is for use in clinical trials , where data must be ... importance of the answers sought and the likelihood that the study will provide them , not by THE NEW ERA OF QUALITY OF ...
Page 8
... important considerations . Chief among these is the validity , or relev- ance , of the data to the question at hand . Here , I believe that the traditional medical approaches to evaluating data can gain from the more sophisticated ...
... important considerations . Chief among these is the validity , or relev- ance , of the data to the question at hand . Here , I believe that the traditional medical approaches to evaluating data can gain from the more sophisticated ...
Page 11
... important as other goals of health and medical care , such as preventing disease , effecting a cure , alleviating symptoms or pain , averting complications , providing humane care , and prolonging life . Quality of life can be ...
... important as other goals of health and medical care , such as preventing disease , effecting a cure , alleviating symptoms or pain , averting complications , providing humane care , and prolonging life . Quality of life can be ...
Page 15
... important ones . Even if morbidity and longevity are unaffected , health promotion may enhance health by increasing energy , stamina , feelings of well - being , resi- lience , autonomy , and productivity . These are outcomes ...
... important ones . Even if morbidity and longevity are unaffected , health promotion may enhance health by increasing energy , stamina , feelings of well - being , resi- lience , autonomy , and productivity . These are outcomes ...
Contents
11 | |
rationale for a single | 65 |
Development testing and use of the Sickness Impact | 95 |
The Nottingham Health Profile | 111 |
an update | 131 |
A health index and output measure | 151 |
A fifteendimensional measure of healthrelated quality | 185 |
The EuroQol quality of life project | 197 |
Measurement of healthrelated quality of life in asthma | 301 |
Measuring quality of life in hypertension | 321 |
Measuring the quality of life of patients with angina | 333 |
Measuring quality of life in psychiatry | 343 |
Measuring the quality of life of patients with skin disease | 355 |
Ethical questions and their implication for QOL studies | 373 |
Industry perspectives on quality of life | 383 |
A regulatory view | 393 |
Indices versus profiles advantages and disadvantages | 209 |
The OnLine Guide to QualityofLife Assessment | 221 |
Measuring the quality of life of patients with cancer | 235 |
Measuring the quality of life of patients with rheumatoid | 269 |
Measuring the quality of life of patients with Parkinsons | 289 |
The cost effectiveness of pharmaceuticals | 401 |
Requirements for health care purchasers | 413 |
The importance of quality of life in policy decisions | 427 |
Appendices | 441 |
Other editions - View all
Quality of Life Assessment: Key Issues in the 1990s S R Walker,Rachel M Rosser No preview available - 1992 |
Quality of Life Assessment: Key Issues in the 1990s S.R. Walker,Rachel M. Rosser No preview available - 2012 |
Common terms and phrases
ACE inhibitors activities airways disease analysis angina antihypertensive application areas aspects Assessment of Quality asthma atenolol auranofin behaviour benefits cancer patients captopril chronic cilazapril clinical trials clinician compared comparison components concepts coronary correlation cost depression dimensions disability distress domains drug dysfunction effects evaluation example factors function scores groups health services health status measures health-related quality hospital hypertension illness impairment important improvement indicators individual instrument interventions interview investigator Kaplan levodopa measure of health measurement of quality medicine methodological methods methyldopa mobility morbidity mortality nifedipine outcome overall pain Parkinson's disease performance physical function placebo population problems propranolol psychiatric psychological psychometric psychosocial QALY questionnaire questions reliability respiratory response rheumatoid arthritis Rosser scale self-administered sensitivity Sickness Impact Profile side-effects SIP score specific standard standard gamble statistical surgery symptoms Table testing therapy treatment validity valuation verapamil weights well-years